A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVIV Vaccine in Patients With Ovarian Cancer After Surgery
Clinical trial NCT07676890 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07676890
- Sponsor
- West China Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-31
- Primary completion
- 2028-05-30
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.